The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Global, regional, and national prevalence, incidence, mortality, and risk factors for atrial fibrillation, 1990–2017: results from the Global Burden of Disease Study 2017
Open accessAbstract
Aims: To estimate the prevalence, incidence, mortality, and risk factors for atrial fibrillation (AF) in 195 countries and territories from 1990 to 2017. Methods and results: Following the methodologies used in the Global Burden of Disease Study 2017, the prevalence, incidence, and mortality of AF were analysed by age, sex, year, socio-demographic index (SDI), and location. The percentage contributions of major risk factors to age-standardized AF deaths were measured by population attributable fractions. In 2017, there were 37.57 million [95% uncertainty interval (UI) 32.55–42.59] prevalent cases and 3.05 million (95% UI 2.61–3.51) incident cases of AF globally, contributing to 287 241 (95% UI 276 355–304 759) deaths. The age-standardized rates of prevalent cases, incident cases, and deaths of AF in 2017 and their temporal trends from 1990 to 2017 varied significantly by SDI quintile and location. High systolic blood pressure was the leading risk factor for AF age-standardized deaths [34.3% (95% UI 27.4–41.5)] in 2017, followed by high body mass index [20.7% (95% UI 11.5–32.2)] and alcohol use [9.4% (95% UI 7.0–12.2)]. Conclusion: Our study has systematically and globally assessed the temporal trends of AF, which remains a major public heath challenge. Although AF mainly occurred in developed countries, the unfavourable trend in countries with lower SDI also deserves particular attention. More effective prevention and treatment strategies aimed at counteracting the increase in AF burden should be established in some countries.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
James, S. L., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32279-7 · Cited by 13,867
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Roth, G. A., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32203-7 · Cited by 8,600
Ruff, C. T., Giugliano, R. P., Braunwald, E., Hoffman, E. B., Deenadayalu, N., Ezekowitz, M. D., Camm, A. J., Weitz, J. I., Lewis, B. S., Parkhomenko, A., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62343-0 · Cited by 5,051 · cited 1×
“7,8 However, in the existing scholarly literature, there is a dearth of data concerning the global burden of AF.”
Stanaway, J. D., Afshin, A., Gakidou, E., Lim, S. S., Abate, D., Abate, K. H., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32225-6 · Cited by 4,943
Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study
Chugh, S. S., Havmoeller, R., Narayanan, K., Singh, D., Rienstra, M., Benjamin, E. J., Gillum, R. F., Kim, Y.-H., McAnulty, J. H., Zheng, Z.-J., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.005119 · Cited by 4,506
Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07495-8 · Cited by 4,492 · cited 1×
“3,24 Currently available evidence reveals that AF might be related to various aetiological factors, including adverse stressors, structural heart disease, endocrine system disease, and genetic factors.”
Kyu, H. H., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32335-3 · Cited by 4,081
Miyasaka, Y., Barnes, M. E., Gersh, B. J., Cha, S. S., Bailey, K. R., Abhayaratna, W. P., Seward, J. B., & Tsang, T. S. M. (2006) · Circulation · doi:10.1161/circulationaha.105.595140 · Cited by 2,564 · cited 1×
“4,5 The reasons and factors underlying such increases have yet to be elucidated, and included population ageing, improved survival, and enhanced detection, among others.”
EAFT (European Atrial Fibrillation Trial) Study Group (1993) · The Lancet · doi:10.1016/0140-6736(93)92358-z · Cited by 1,741
Stewart, S., Hart, C. L., Hole, D. J., & McMurray, J. J. V. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01236-6 · Cited by 1,562
Mant, J., Hobbs, F. R., Fletcher, K., Roalfe, A., Fitzmaurice, D., Lip, G. Y., & Murray, E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61233-1 · Cited by 1,556 · cited 1×
“21 Although more and more studies supported anticoagulation in elder patients (>80years), 22,23 results from present studies reflect that in real-world clinical work, the effort was ineffective to some extent.”
Krijthe, B. P., Kunst, A., Benjamin, E. J., Lip, G. Y. H., Franco, O. H., Hofman, A., Witteman, J. C. M., Stricker, B. H., & Heeringa, J. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht280 · Cited by 1,419
Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial Fibrillation
Ezekowitz, M. D., Bridgers, S. L., James, K. E., Carliner, N. H., Colling, C. L., Gornick, C. C., Krause-Steinrauf, H., Kurtzke, J. F., Nazarian, S. M., Radford, M. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211123272002 · Cited by 1,160
Lead Exposure and Cardiovascular Disease—A Systematic Review
Navas-Acien, A., Guallar, E., Silbergeld, E. K., & Rothenberg, S. J. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.9785 · Cited by 1,112
Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial Fibrillation
(1993) · New England Journal of Medicine · doi:10.1056/nejm199301143280227 · Cited by 1,067
Liu, Z., Jiang, Y., Yuan, H., Fang, Q., Cai, N., Suo, C., Jin, L., Zhang, T., & Chen, X. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.12.001 · Cited by 823
Global epidemiology of atrial fibrillation
Rahman, F., Kwan, G. F., & Benjamin, E. J. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.118 · Cited by 731
Low-level lead exposure and mortality in US adults: a population-based cohort study
Lanphear, B. P., Rauch, S., Auinger, P., Allen, R. W., & Hornung, R. W. (2018) · The Lancet Public Health · doi:10.1016/s2468-2667(18)30025-2 · Cited by 613
Emdin, C. A., Wong, C. X., Hsiao, A. J., Altman, D. G., Peters, S. A., Woodward, M., & Odutayo, A. A. (2016) · BMJ · doi:10.1136/bmj.h7013 · Cited by 452
Patel, N. J., Deshmukh, A., Pant, S., Singh, V., Patel, N., Arora, S., Shah, N., Chothani, A., Savani, G. T., Mehta, K., et al. (2014) · Circulation · doi:10.1161/circulationaha.114.008201 · Cited by 429
Ruddox, V., Sandven, I., Munkhaugen, J., Skattebu, J., Edvardsen, T., & Otterstad, J. E. (2017) · European Journal of Preventive Cardiology · doi:10.1177/2047487317715769 · Cited by 407
Oldgren, J., Healey, J. S., Ezekowitz, M., Commerford, P., Avezum, A., Pais, P., Zhu, J., Jansky, P., Sigamani, A., Morillo, C. A., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.005451 · Cited by 365
Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis
Ko, D., Rahman, F., Schnabel, R. B., Yin, X., Benjamin, E. J., & Christophersen, I. E. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.45 · Cited by 353 · cited 1×
“15,16 Females with AF were more likely symptomatic, with relatively more severe symptoms, and associated with higher risks of cardiovascular diseases and mortality when compared with males.”
Screening to identify unknown atrial fibrillation: A systematic review
Lowres, N., Neubeck, L., Redfern, J., & Freedman, S. B. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-02-0165 · Cited by 327
European Ancestry as a Risk Factor for Atrial Fibrillation in African Americans
Marcus, G. M., Alonso, A., Peralta, C. A., Lettre, G., Vittinghoff, E., Lubitz, S. A., Fox, E. R., Levitzky, Y. S., Mehra, R., Kerr, K. F., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.958306 · Cited by 255
Screening for atrial fibrillation: a call for evidence
Jones, N. R., Taylor, C. J., Hobbs, F. D. R., Bowman, L., & Casadei, B. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz834 · Cited by 178
Gender differences in clinical presentation and 1-year outcomes in atrial fibrillation
Schnabel, R. B., Pecen, L., Ojeda, F. M., Lucerna, M., Rzayeva, N., Blankenberg, S., Darius, H., Kotecha, D., Caterina, R. D., & Kirchhof, P. (2017) · Heart · doi:10.1136/heartjnl-2016-310406 · Cited by 176
Type 2 diabetes mellitus and atrial fibrillation: From mechanisms to clinical practice
Tadić, M., & Cuspidi, C. (2015) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2015.01.009 · Cited by 144
Sex Differences in Atrial Fibrillation
Andrade, J. G., Deyell, M. W., Lee, A. K. Y., & Macle, L. (2017) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.11.022 · Cited by 113
Fall risk and anticoagulation for atrial fibrillation in the elderly: A delicate balance
Hagerty, T., & Rich, M. W. (2017) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.84a.16016 · Cited by 57
Eum, K.-D., Nie, L. H., Schwartz, J. D., Vokonas, P., Sparrow, D., Hu, H., & Weisskopf, M. G. (2011) · Environmental Health Perspectives · doi:10.1289/ehp.1003279 · Cited by 43
Iron Metabolism Genes, Low-Level Lead Exposure, and QT Interval
Park, S. K., Hu, H., Wright, R. O., Schwartz, J. D., Cheng, Y., Sparrow, D., Vokonas, P., & Weisskopf, M. G. (2008) · Environmental Health Perspectives · doi:10.1289/ehp.11559 · Cited by 35
Atrial fibrillation and heart failure- results of the CASTLE-AF trial
Shah, S. R., Moosa, P. G., Fatima, M., Ochani, R. K., Shahnawaz, W., Jangda, M. A., & Shah, S. A. (2018) · Journal of Community Hospital Internal Medicine Perspectives · doi:10.1080/20009666.2018.1495979 · Cited by 20
Åsberg, S., Eriksson, M., Henriksson, K. M., & Terént, A. (2012) · International Journal of Stroke · doi:10.1111/j.1747-4949.2012.00855.x · Cited by 10
Cited by
Van Gelder, I. C., Rienstra, M., Bunting, K. V., Casado-Arroyo, R., Caso, V., Crijns, H. J. G. M., De Potter, T. J. R., Dwight, J., Guasti, L., Hanke, T., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae176 · Cited by 3,024
Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001193 · Cited by 2,765
European Society of Cardiology: cardiovascular disease statistics 2021
Timmis, A., Vardas, P., Townsend, N., Torbica, A., Katus, H., De Smedt, D., Gale, C. P., Maggioni, A. P., Petersen, S. E., Huculeci, R., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehab892 · Cited by 1,102
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation
Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.08.017 · Cited by 933
Romiti, G. F., Pastori, D., Rivera-Caravaca, J. M., Ding, W. Y., Gue, Y. X., Menichelli, D., Gumprecht, J., Kozieł, M., Yang, P.-S., Guo, Y., et al. (2022) · Thrombosis and Haemostasis · doi:10.1055/a-1515-9630 · Cited by 428
Metadata
- Authors
- Dai, H., Zhang, Q., Much, A. A., Maor, E., Segev, A., Beinart, R., Adawi, S., Lu, Y., Bragazzi, N. L., & Wu, J.
- Venue
- European Heart Journal - Quality of Care and Clinical Outcomes
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-07-31
- Volume
- 7
- Issue
- 6
- Pages
- 574-582
- ISSN
- 2058-1742 (ISSN-L)
- 2058-5225
- OpenAlex
- W3046824776
- Cited by
- 322
- References
- 36
- FWCI
- 21.93
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.